Key Takeaways Palantir shares tumbled Thursday on expectations of defense spending cuts; this week's losses put the stock in ...

Palantir shares continued to decline on Thursday, extending a sharp sell-off. The stock fell nearly 9%, following Wednesday’s ...

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here’s ...

U.S. defense stocks opened in the red on Thursday, Feb. 20 following reports that President Donald Trump’s administration has ...

Wedbush reiterated its outperform rating on TSLA with a $550 price target, representing a 55.08% increase from the current ...

Palantir (PLTR) stock is tumbling 11% after its CEO implemented a new stock-trading plan and a report stated that the ...

In today’s CEO Daily: Diane Brady with President Trump at FII in Miami. The big story: Trump v the World. The markets: ...

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a research note issued to investors on Tuesday,RTT News reports. They ...

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They ...

Apple's iPhone 16e is priced higher than expected - but it has AI Apple Inc.'s newest lower-priced iPhone costs more than Wall Street expected, but it includes artificial-intelligence features ...